DOW CHEMICAL CO /DE/
For the period ended Dec 31, 2025. Filed Feb 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 3, 2026
DOW$31.48+1.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Income
| (In millions) For the years ended Dec 31, | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net sales | $39,968 | $42,964 | $44,622 |
| Cost of sales | 37,431 | 38,346 | 39,738 |
| Research and development expenses | 752 | 810 | 829 |
| Selling, general and administrative expenses | 1,392 | 1,581 | 1,627 |
| Amortization of intangibles | 231 | 310 | 324 |
| Restructuring, goodwill impairment and asset related charges - net | 1,856 | 103 | 528 |
| Equity in losses of nonconsolidated affiliates | (240) | (6) | (119) |
| Sundry income (expense) - net | 157 | 404 | (327) |
| Interest income | 156 | 210 | 239 |
| Interest expense and amortization of debt discount | 865 | 811 | 746 |
| Income (loss) before income taxes | (2,486) | 1,611 | 623 |
| Provision (credit) for income taxes | (67) | 399 | (4) |
| Net income (loss) | (2,419) | 1,212 | 627 |
| Net income attributable to noncontrolling interests | 179 | 85 | 71 |
| Net income (loss) available for The Dow Chemical Company common stockholder | $(2,598) | $1,127 | $556 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.